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Abstract
To assess the prevalence of Toscana virus (TOSV) infection
among healthy residents of Croatia we tested sera from 2016
persons, for IgG antibodies to TOSV, by an enzyme immunoas-
say. A total of 755 (37.5%) persons had IgG antibodies to TOSV:
53.9%, 33.6% and 6.1% among residents of the islands, coastal
area and mainland of Croatia, respectively. Risk factors signiﬁ-
cantly associated with seropositivity to TOSV were: living on
islands (OR, 11.10; 95% CI, 6.02–20.50; p <0.001) or in coastal
areas (OR, 6.96; 95% CI, 3.81–12.71; p <0.001) and increase of
age (OR, 1.03; 95% CI, 1.02–1.03; p <0.001).
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Toscana virus (TOSV) (family Bunyaviridae, genus Phlebovirus)
is an arbovirus transmitted by sandﬂies (Phlebotomus spp).
TOSV is neurovirulent and causes aseptic meningitis during
the summer time in both residents of and travellers to Medi-
terranean countries [1–4].
No information on TOSV circulation in Croatia is avail-
able. The aim of this study was to determine the prevalence
of TOSV antibodies among the healthy population of differ-
ent regions in Croatia.
Croatia is situated between central and south-eastern Eur-
ope, lying along the east coast of the Adriatic Sea (Fig. 1).
The Croatian littoral is composed of the northern (Istria and
Primorje) and southern part (Dalmatia), which is subdivided
into northern, central and southern Dalmatia. The Adriatic
coast and islands are characterized by the Mediterranean cli-
mate, which is favourable for maintaining sandﬂy vectors of
TOSV [5]. The mainland parts of Croatia, which have the
continental climate, are considered sandﬂy-free areas.
From 2007 to 2009 we collected blood specimens from
2016 healthy inhabitants of island, coastal or continental
parts of Croatia, aged 8 months to 88 years, who came to
hospital for laboratory check-ups or blood donation. Infor-
mation regarding age, gender and site of residence was col-
lected. The ethical committee of Split University Hospital
approved the study.
Presence of anti-TOSV IgG was investigated using a com-
mercial enzyme immunoassay (rEIA, Enzywell Toscana Virus
IgG/IgM, DIESSE, Siena, Italy). Previous studies of rEIA had
revealed its sensitivity and speciﬁcity for IgM to be 100%,
and for IgG to be 100 and 96.6%, respectively [6].
The data were analyzed using SPSS version 19.0. Chi-
square tests, odds ratios (OR) and multiple logistic regres-
sion were used to estimate associations with seropositivity
and to evaluate potential risk factors for TOSV infection.
Of the total of 2016 sera, anti-TOSV IgG were found in
755 (37.5%). Seroprevalence differed signiﬁcantly among
sites, ranging from 4.7% in Brod-Posavina County to 67.7%
on the island of Lastovo (Fig. 1, Table 1). Islanders were
more seropositive than inhabitants of coastal (v2 = 69.82, p
<0.001) or mainland areas (v2 = 139.33, p <0.001). Inhabit-
ants of coastal areas were more seropositive than those
from mainland regions (v2 = 61.46, p <0.001).
Prevalences among the coastal and continental counties,
as well as between the islands, were compared (Table 1).
With regard to islands data, a decrease in risk of TOSV
infection was determined for the northern-most islands of
Istria and Primorje (Fig. 1) relative to islands of central
(OR = 0.52; 95% CI, 0.33–0.84; p 0.007) or southern Dalma-
tia (OR = 0.61; 95% CI, 0.35–1.04; p 0.070 borderline signiﬁ-
cance).
All endemic sites (coastal or island) had signiﬁcantly higher
risk of TOSV infection, compared with the continental coun-
ties (OR from 6.46 to 21.39; p <0.001).
An increased probability of acquiring the infection with age
was observed. Seroprevalence rate increased from 10.2% in
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children 0–9 years old to 70.7% in people over the age of 70,
thereby increasing the risk of infection up to OR of 16.42.
Multivariate logistic regression found that older age and
living on the coast or an island to be signiﬁcantly associated
with seropositivity to TOSV (Table 1).
To the best of our knowledge, this is the ﬁrst study of
prevalence of TOSV antibodies in Croatia. In order to deter-
mine the TOSV infection distribution, residents of various
geographical areas were included in the study. Two counties
in continental Croatia, which are not considered endemic for
sandﬂies, were studied for comparison. The commercial rEIA
test was used because many TOSV seroprevalence studies
were based on this test [3,7–13].
As we presumed, the seroprevalence was signiﬁcantly
lower in residents of continental areas of Croatia. As people
from the mainland often travel to the Croatian littoral for
summer vacations, we cannot exclude the possibility of them
being infected there. It is known that in people visiting ende-
mic areas TOSV infections may occur without any signs of
illness [3,4,13,14]. One could also speculate that autochtho-
nous TOSV infection may occur due to the observed spread
of sandﬂies to the central European region [1,14,15].
TOSV infection is found throughout the Croatian littoral
stretching from Istria to the Montenegro border. Observed
seroprevalence appears to be variable according to the
geographical site of study. Similar dispersal patterns, which
FIG. 1 Map of Croatia showing the geographical distribution of Toscana virus seroprevalence.
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correlate with favourable habitat for sandﬂies, have been
observed in other Mediterranean countries [8,11,16]. The
mean prevalence in the coastal zones was 33.6%, with the
highest prevalence of 39.9% in southern Dalmatia. Between
different islands the mean seroprevalence rate was 53.9%,
with the lowest prevalence being 19.2% on the island of
Cres. Residents of central and southern Dalmatia islands
were signiﬁcantly more likely to be TOSV seropositive than
residents of the northern islands. The prevalence of antibody
to TOSV on the island of Lastovo, the most outlying island
of Croatia (67.7%), is among the highest in Mediterranean
countries. A similar prevalence of 61.0% was found on the
Spanish island of Mallorca [16] and lower prevalence from
39% to 51.7% was found among inhabitants of two Greek
islands [11].
Data from seroepidemiological studies conducted in other
Mediterranean countries have also shown a variable preva-
lence of TOSV infections depending on the geographical
regions and other risk factors [1–4,7–13,16–18]. The highest
seroprevalence (77.2%) reported to date was observed
among forestry workers in the endemic zone of Tuscany,
Italy [4,8].
In our study the frequency of antibodies increased with
age, suggesting regular exposure to TOSV through time. The
recent circulation of TOSV in the region is evident from the
presence of antibodies in the serum of a 1-year-old girl from
southern Dalmatia and in 10.2% of sera of children under
the age of 9. The age-dependent increase was also observed
in other studies [4,7–11].
In conclusion, our results have shown that the Croatian
littoral areas are endemic for TOSV. Physicians should be
aware of the circulation of TOSV, which must be considered
as an aetiological agent in cases of summer aseptic meningitis
in local residents as well as in travellers to the region. Fur-
ther studies including clinical, virological and entomological
investigation are needed for elucidating the role of TOSV in
public health in Croatia.
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